tirzepatide and retinopathy Semaglutide vs Tirzepatide: DR Risk Clinical Implications | Paramesh Shamanna posted on the topic Tirzepatide Linked to Reduced Risk

In 2021, a landmark trial conducted at Northwestern Medicine found that the antidiabetic drug semaglutide was twice as effective in helping individuals lose weight than other weight-loss drugs on the market

The same dosing recommendations apply, and no additional symptoms have been observed

The hereditary predisposition often runs unnoticed beneath the surface for years

"*" indicates required fields GET 10% OFF ON YOUR FIRST IV THERAPY OR VITAMIN INJECTION SERVICE WITH US Not valid with other offers

Overall, GLP-1 and GLP-1RAs (as shown in Figure 2) can improve lung function, and airway remodeling, reduce mucus secretion, reduce disease risk and mortality through a variety of pathways, and may hold potential promise in the treatment of airway disease, 80 but GLP-1RAs are not approved for the treatment of COPD, so further studies are needed to confirm this

It would remain to be seen whether, for example, activation of the large population of colonic L cells, for which it is difficult to assign a clear postprandial role, might occur under such conditions